Therapeutic drug measurement of mycophenolic acid derivatives in transplant patients

Clinical Biochemistry

Volumn 40, Issue 11, 2007, Pages 752-764

  Elbarbry, Fawzy A ^a   Shoker, Ahmed S ^a  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

Drug analysis; HPLC; Immunoassays; Mycophenolic acid; Therapeutic drug monitoring; Transplantation

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; DRUG METABOLITE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYCOPHENOLIC ACID ACYL GLUCURONIDE; MYCOPHENOLIC ACID BETA D GLUCURONIDE; TACROLIMUS; UNCLASSIFIED DRUG;

ANALYTIC METHOD; CHROMATOGRAPHY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG METABOLISM; DRUG STABILITY; DRUG URINE LEVEL; FEASIBILITY STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; LIQUID LIQUID EXTRACTION; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SAMPLING; SOLID PHASE EXTRACTION; TRANSPLANTATION; VALIDATION STUDY;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; IMMUNOASSAY; MYCOPHENOLIC ACID; PRODRUGS; TRANSPLANTS;

EID: 34250727608     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.03.006     Document Type: Review

References (66)

1. Port F.K., Merion R.M., Goodrich N.P., and Wolfe R.A. Recent trends and results for organ donation and transplantation in the United States, 2005. Am. J. Transplant 6 (2006) 1095-1100
2. Bullingham R.E., Nicholls A.J., and Kamm B.R. Clinical pharmacokinetics of mycophenolate mofetil. Clin. Pharmacokinet. 34 (1998) 429-455
3. Halloran P., Mathew T., Tomlanovich S., Groth C., Hooftman L., and Barker C. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation 63 (1997) 39-47
4. Squifflet J.P., Backman L., Claesson K., Dietl K.H., Ekberg H., Forsythe J.L., et al. Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients. Transplantation 72 (2001) 63-69
5. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet (1995) 1321-1325
6. Dudley C., Pohanka E., Riad H., Dedochova J., Wijngaard P., Sutter C., et al. Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the creeping creatinine study. Transplantation 79 (2005) 466-475
7. Suwelack B., Gerhardt U., and Hohage H. Withdrawal of cyclosporine or tacrolimus after addition of mycophenolate mofetil in patients with chronic allograft nephropathy. Am. J. Transp. 4 (2004) 655-662
8. van G.T., Le M.Y., Shaw L.M., Oellerich M., DeNofrio D., Holt C., et al. Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Ther. Drug Monit. 28 (2006) 145-154
9. Shaw L.M., Holt D.W., Oellerich M., Meiser B., and van G.T. Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Ther. Drug Monit. 23 (2001) 305-315
10. Premaud A., Rousseau A., Picard N., and Marquet P. Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry. Ther. Drug Monit. 28 (2006) 274-277
11. Borrows R., Chusney G., James A., Stichbury J., Van T.J., Cairns T., et al. Determinants of mycophenolic acid levels after renal transplantation. Ther. Drug Monit. 27 (2005) 442-450
12. Millan O., Brunet M., Martorell J., Garcia F., Vidal E., Rojo I., et al. Pharmacokinetics and pharmacodynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavir. Clin. Pharmacokinet. 44 (2005) 525-538
13. Hale M.D., Nicholls A.J., Bullingham R.E., Hene R., Hoitsma A., Squifflet J.P., et al. The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clin. Pharmacol. Ther. 64 (1998) 672-683
14. DeNofrio D., Loh E., Kao A., Korecka M., Pickering F.W., Craig K.A., et al. Mycophenolic acid concentrations are associated with cardiac allograft rejection. J. Heart Lung Transplant. 19 (2000) 1071-1076
15. van Hest R.M., Hesselink D.A., Vulto A.G., Mathot R.A., and van G.T. Individualization of mycophenolate mofetil dose in renal transplant recipients. Expert Opin. Pharmacother. 7 (2006) 361-376
16. Staatz C.E., Duffull S.B., Kiberd B., Fraser A.D., and Tett S.E. Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation. Eur. J. Clin. Pharmacol. 61 (2005) 507-516
17. Kiberd B.A., Lawen J., Fraser A.D., Keough-Ryan T., and Belitsky P. Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation. Am. J. Transp. 4 (2004) 1079-1083
18. van Hest R.M., Mathot R.A., Pescovitz M.D., Gordon R., Mamelok R.D., and van G.T. Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients. J. Am. Soc. Nephrol. 17 (2006) 871-880
19. Pelletier R.P., Akin B., Henry M.L., Bumgardner G.L., Elkhammas E.A., Rajab A., et al. The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation. Clin. Transplant. 17 (2003) 200-205
20. Nowak I., and Shaw L.M. Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics. Clin. Chem. 41 (1995) 1011-1017
21. Shaw L.M., Mick R., Nowak I., Korecka M., and Brayman K.L. Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function. J. Clin Pharmacol. 38 (1998) 268-275
22. Atcheson B.A., Taylor P.J., Kirkpatrick C.M., Duffull S.B., Mudge D.W., Pillans P.I., et al. Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia. Ther. Drug Monit. 26 (2004) 284-286
23. Weber L.T., Shipkova M., Armstrong V.W., Wagner N., Schutz E., Mehls O., et al. The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the German study group on mycophenolate mofetil therapy. J. Am. Soc. Nephrol. 13 (2002) 759-768
24. Bullingham R., Monroe S., Nicholls A., and Hale M. Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration. J. Clin. Pharmacol. 36 (1996) 315-324
25. Naito T., Shinno K., Maeda T., Kagawa Y., Hashimoto H., Otsuka A., et al. Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation. Biol. Pharm. Bull. 29 (2006) 275-280
26. Akhlaghi F., Patel C.G., Zuniga X.P., Halilovic J., Preis I.S., and Gohh R.Y. Pharmacokinetics of mycophenolic acid and metabolites in diabetic kidney transplant recipients. Ther. Drug Monit. 28 (2006) 95-101
27. Patel C.G., and Akhlaghi F. High-performance liquid chromatography method for the determination of mycophenolic acid and its acyl and phenol glucuronide metabolites in human plasma. Ther. Drug Monit. 28 (2006) 116-122
28. Bolon M., Jeanpierre L., El B.M., Chelbi K., Sauviat M., and Boulieu R. HPLC determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma with hybrid material. J. Pharm. Biomed. Anal. 36 (2004) 649-651
29. Patel C.G., Mendonza A.E., Akhlaghi F., Majid O., Trull A.K., Lee T., et al. Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry. J. Chromatogr., B Analyt. Technol. Biomed Life Sci. 813 (2004) 287-294
30. Pastore A., Lo R.A., Piemonte F., Mannucci L., and Federici G. Rapid determination of mycophenolic acid in plasma by reversed-phase high-performance liquid chromatography. J. Chromatogr., B Analyt. Technol. Biomed Life Sci. 776 (2002) 251-254
31. Shipkova M., Schutz E., Armstrong V.W., Niedmann P.D., Oellerich M., and Wieland E. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit. Clin. Chem. 46 (2000) 365-372
32. Shipkova M., Niedmann P.D., Armstrong V.W., Schutz E., Wieland E., Shaw L.M., et al. Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure. Clin. Chem. 44 (1998) 1481-1488
33. Premaud A., Rousseau A., Le M.Y., Lachatre G., and Marquet P. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring. Ther. Drug Monit. 26 (2004) 609-619
34. Annesley T.M., and Clayton L.T. Quantification of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry. Clin. Chem. 51 (2005) 872-877
35. Streit F., Shipkova M., Armstrong V.W., and Oellerich M. Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid. Clin. Chem. 50 (2004) 152-159
36. Atcheson B., Taylor P.J., Mudge D.W., Johnson D.W., Pillans P.I., and Tett S.E. Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection. J. Chromatogr., B Analyt. Technol. Biomed. Life Sci. 799 (2004) 157-163
37. Na-Bangchang K., Supasyndh O., Supaporn T., Banmairuroi V., and Karbwang J. Simple and sensitive high-performance liquid chromatographic. J. Chromatogr., B. Biomed. Sci. Appl. 738 (2000) 169-173
38. Sugioka N., Odani H., Ohta T., Kishimoto H., Yasumura T., and Takada K. Determination of a new immunosuppressant, mycophenolate mofetil, and its active metabolite, mycophenolic acid, in rat and human body fluids by high-performance liquid chromatography. J. Chromatogr., B Biomed. Appl. 654 (1994) 249-256
39. Bahrami G., and Mohammadi B. An isocratic high performance liquid chromatographic method for quantification of mycophenolic acid and its glucuronide metabolite in human serum using liquid-liquid extraction: application to human pharmacokinetic studies. Clin. Chim. Acta 370 (2006) 185-190
40. Aresta A., Palmisano F., Zambonin C.G., Schena P., and Grandaliano G. Simultaneous determination of free mycophenolic acid and its glucuronide in serum of patients under mycophenolate mophetil therapy by ion-pair reversed-phase liquid chromatography with diode array UV detection. J. Chromatogr., B Analyt. Technol. Biomed. Life Sci. 810 (2004) 197-202
41. Zambonin C.G., Aresta A., and Palmisano F. Determination of the immunosuppressant mycophenolic acid in human serum by solid-phase microextraction coupled to liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 806 (2004) 89-93
42. Westley I.S., Sallustio B.C., and Morris R.G. Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasma. Clin. Biochem. 38 (2005) 824-829
43. Mehdi A., and Rezaee S. Determination of mycophenolic acid in human plasma by high-performance liquid chromatography. DARU (2005) 13
44. Yau W.P., Vathsala A., Lou H.X., and Chan E. Simple reversed-phase ion-pair liquid chromatography assay for the simultaneous determination of mycophenolic acid and its glucuronide metabolite in human plasma and urine. J. Chromatogr., B Analyt. Technol. Biomed Life Sci. 805 (2004) 101-112
45. Khoschsorur G., and Erwa W. Liquid chromatographic method for simultaneous determination of mycophenolic acid and its phenol- and acylglucuronide metabolites in plasma. J. Chromatogr. B Biomed Appl. (2004) 355-360
46. Srivatsan V., Dasgupta A.K., Kale P., Verma R., Joshi P., Soni D., et al. Determination of mycophenolic acid in human plasma by high-performance liquid chromatography. J. Chromatogr, A 1031 (2004) 259-264
47. Elbarbry F.A., and Shoker A. Simple high performance liquid chromatographic assay for mycophenolic acid in renal transplant patients. J. Pharm. Biomed. Anal. 43 (2007) 788-792
48. Teshima D., Kitagawa N., Otsubo K., Makino K., Itoh Y., and Oishi R. Simple determination of mycophenolic acid in human serum by column-switching high-performance liquid chromatography. J. Chromatogr., B Analyt. Technol. Biomed Life Sci. 780 (2002) 21-26
49. Yau W.P., Vathsala A., Lou H.X., Zhou S., and Chan E. Simple reversed-phase liquid chromatographic assay for simultaneous quantification of free mycophenolic acid and its glucuronide metabolite in human plasma. J. Chromatogr., B Biomed. Appl. 846 1-2 (2007) 313-318
50. Shen J., Jiao Z., Yu Y.Q., Zhang M., and Zhong M.K. Quantification of total and free mycophenolic acid in human plasma by liquid chromatography with fluorescence detection. J. Chromatogr., B Analyt. Technol. Biomed Life Sci. 817 (2005) 207-213
51. Mandla R., Line P.D., Midtvedt K., and Bergan S. Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients. Ther. Drug Monit. 25 (2003) 407-414
52. Svensson J.O., Brattstrom C., and Sawe J. A simple HPLC method for simultaneous determination of mycophenolic acid and mycophenolic acid glucuronide in plasma. Ther. Drug Monit. 21 (1999) 322-324
53. Indjova D., Kassabova L., and Svinarov D. Simultaneous determination of mycophenolic acid and its phenolic glucuronide in human plasma using an isocratic high-performance liquid chromatography procedure. J. Chromatogr., B Analyt. Technol. Biomed. Life Sci. 817 (2005) 327-330
54. Brandhorst G., Streit F., Goetze S., Oellerich M., and Armstrong V.W. Quantification by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites. Clin. Chem. 52 (2006) 1962-1964
55. Watson D.G., Araya F.G., Galloway P.J., and Beattie T.J. Development of a high pressure liquid chromatography method for the determination of mycophenolic acid and its glucuronide metabolite in small volumes of plasma from paediatric patients. J. Pharm. Biomed. Anal. 35 (2004) 87-92
56. Wiwattanawongsa K., Heinzen E.L., Kemp D.C., Dupuis R.E., and Smith P.C. Determination of mycophenolic acid and its phenol glucuronide metabolite in human plasma and urine by high-performance liquid chromatography. J. Chromatogr., B Biomed. Sci. Appl. 763 (2001) 35-45
57. Hosotsubo H., Takahara S., Imamura R., Kyakuno M., Tanaka T., Yazawa K., et al. Analytic validation of the enzyme multiplied immunoassay technique for the determination of mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatographic assay. Ther. Drug Monit. 23 (2001) 669-674
58. Mendonza A.E., Gohh R.Y., and Akhlaghi F. Analysis of mycophenolic acid in saliva using liquid chromatography tandem mass spectrometry. Ther. Drug Monit. 28 (2006) 402-406
59. Hosotsubo H., Takahara S., Kokado Y., Permpongkosol S., Wang J.D., Tanaka T., et al. Rapid and simple determination of mycophenolic acid in human plasma by ion-pair RP-LC with fluorescence detection. J. Pharm. Biomed. Anal. 24 (2001) 555-560
60. Yoshihiro A., Yasushi K., and Ribert N. Immunoassays and Immunohistochemistry. In: Henry J.B. (Ed). Clinical Diagnosis and Management by Laboratory Methods vol. 1 (2007), W.B. Saunders Company, Philadelphia 821-849
61. Mian I.S., Bradwell A.R., and Olson A.J. Structure, function and properties of antibody binding sites. J. Mol. Biol. 217 (1991) 133-151
62. Hyneck M.L., Munafo A., and Benet L.Z. Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide. Drug Metab. Dispos. 16 (1988) 322-324
63. Westley I.S., Ray J.E., and Morris R.G. CEDIA mycophenolic acid assay compared with HPLC-UV in specimens from transplant recipients. Ther. Drug Monit. 28 (2006) 632-636
64. Beal J.L., Jones C.E., Taylor P.J., and Tett S.E. Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay. Ther. Drug Monit. 20 (1998) 685-690
65. Schutz E., Shipkova M., Armstrong V.W., Niedmann P.D., Weber L., Tonshoff B., et al. Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites. Transplant. Proc. 30 (1998) 1185-1187
66. Shipkova M., Armstrong V.W., Kiehl M.G., Niedmann P.D., Schutz E., Oellerich M., et al. Quantification of mycophenolic acid in plasma samples collected during and immediately after intravenous administration of mycophenolate mofetil. Clin. Chem. 47 (2001) 1485-1488